| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $210K | -20.3% |
| Cost of Revenue | $165K | +199.0% |
| Gross Profit | $45K | -78.4% |
| R&D Expense | $369K | -81.0% |
| SG&A Expense | $3.8M | -32.6% |
| Operating Income | -$4.3M | +43.0% |
| Interest Expense | $16 | — |
| Net Income | -$5.2M | +20.4% |
| EPS (Basic) | -$5.43 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | -50.9% |
| Short-term Investments | $234K | — |
| Accounts Receivable | $143K | +33.6% |
| Inventory | $21K | -82.7% |
| Current Assets | $3.4M | -37.7% |
| Total Assets | $5.5M | -24.6% |
| Current Liabilities | $892K | +14.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -5.8% |
| Investing Cash Flow | -$1.9M | -24.3% |
| Financing Cash Flow | $3.0M | -12.3% |
| -200.0% |
| EPS (Diluted) | -$0.89 | -116.4% |
| Total Liabilities |
| $892K |
| +13.5% |
| Stockholders' Equity | $4.7M | -26.7% |